Market Research Report
Asia Pacific Aptamers Market By Type, By Application, By Technology, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
|Asia Pacific Aptamers Market By Type, By Application, By Technology, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027|
Published: January 31, 2022
Content info: 84 Pages
Delivery time: 1-2 business days
The Asia Pacific Aptamers Market would witness market growth of 17.7% CAGR during the forecast period (2021-2027).
Aptamer technology has become more effective and authoritative since then, and the number of studies on aptamer uses is continuously expanding. Aptamers can be used in a variety of fields. Antibodies are the most widely used class of molecules for molecular recognition in a variety of applications for more than three decades. Aptamers are commonly used as a replacement for antibodies due to their ability to overcome the flaws of antibodies.
Aptamers have a high level of stability. Proteins are easily denatured and lose their tertiary structure at high temperatures, whereas oligonucleotides are more thermally robust and preserve their structures over multiple denaturation/renaturation cycles. As a result, the most significant benefit of oligonucleotide-based aptamers over protein-based antibodies is their temperature stability.
Furthermore, one of the primary factors driving the market's growth is the rising acceptability of personalized medicine. Aptamers have evolved quickly over the last ten years, and they've been used to target a variety of molecules implicated in tumor growth and metastasis at various locales. Hence, these factors are estimated to speed up the growth of the regional Aptamers market during the forecasting period.
The China market dominated the Asia Pacific Aptamers Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $27.6 million by 2027. The Japan market is expected to witness a CAGR of 17% during (2021 - 2027). Additionally, The India market would exhibit a CAGR of 18.4% during (2021 - 2027).
Based on Type, the market is segmented into DNA Aptamers, XNA Aptamers and RNA Aptamers. Based on Application, the market is segmented into Therapeutics Development, Research & Development, Diagnostic and Others. Based on Technology, the market is segmented into SELEX and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Kaneka Corporation, Aptamer Group PLC, SomaLogic, Inc., RayBiotech Life, Inc., Neoventures Biotechnology, Inc., Maravai Lifesciences Holdings, Inc., Aptus Biotech, Base Pair Biotechnologies, Inc., Alpha Diagnostic International, Inc., and Vivonics, Inc.
Market Segments covered in the Report:
By End User
Unique Offerings from KBV Research
List of Figures